ICLR Stock - ICON ADR

ICLR Stock Chart

ICLR Profile

ICON Public Limited Company, headquartered in Dublin, Ireland, operates as a leading global clinical research organization (CRO), offering comprehensive outsourced development and commercialization services across Europe, the United States, and worldwide. Established in 1990, the company specializes in managing and analyzing programs that support all stages of clinical development, from initial compound selection through to Phase I-IV clinical studies.

The core of ICON's services includes a wide array of clinical development solutions such as early development, patient recruitment and retention strategies, analytics, and late-phase research. The company also provides robust data and technology solutions, consulting services, and specialized offerings in medical imaging and laboratory services.

ICON's comprehensive clinical development capabilities encompass project management, site monitoring, data management, biostatistics, medical writing, pharmacovigilance, and clinical supplies management. The company further supports its clients with strategic regulatory consulting, medical communication services, and advisory solutions tailored to meet evolving regulatory requirements and market dynamics.

Catering primarily to the pharmaceutical, biotechnology, and medical device sectors, ICON also collaborates with government and public health organizations. By leveraging its global presence and deep industry expertise, ICON continues to drive innovation in clinical research, contributing to the advancement of new therapies and treatments that improve patient outcomes worldwide.

ICLR Revenue Chart

ICLR Earnings

Analyst Ratings